Liminatus Pharma LIMN
NASDAQ LIMN
$3.22 +0.11 (+3.54%)
As of: Oct 20, 2026 · 2:26 PM EDT

Liminatus Pharma (LIMN) EBT (2024 - 2026)

Updated

Liminatus Pharma (LIMN) recorded EBT of -$1.4 million in Q2 2026, compared with -$1.16 million a year earlier.

Analysis

Liminatus Pharma (LIMN) EBT (2024 - 2026) Analysis & Trends

On a TTM basis, Liminatus Pharma's EBT came in at -$4.14 million as of Jun 30, 2026; for FY2025, it was -$3.11 million.

  • Across earlier years, EBT came in at -$3.55 million in FY2024.
  • The Q2 2026 figure is the lowest quarterly EBT in data going back to Q2 2024.
  • Per Business Quant, the preceding three quarters came in at -$1.12 million (Q1 2026), -$903,262 (Q4 2025) and -$720,222 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 6.75 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 4.28 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 2.80 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -10.25 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -653.00 Mn
10 Liminatus Pharma 3.12 Mn -2.87 Mn - -1.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.40 Mn
Mar 31, 2026 -1.12 Mn
Dec 31, 2025 -903,262.00
Sep 30, 2025 -720,222.00
Jun 30, 2025 -1.16 Mn
Mar 31, 2025 -327,526.00
Dec 31, 2024 -229,752.00
Sep 30, 2024 -601,372.00
Jun 30, 2024 -961,207.00
API Access

Liminatus Pharma EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=LIMN&period=max&api_key=YOUR_API_KEY